Volume 7, Issue 3, Pages (September 1997)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (June 2001)
Advertisements

Volume 7, Issue 5, Pages (November 1997)
Volume 9, Issue 5, Pages (November 1998)
Volume 13, Issue 4, Pages (October 2000)
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 26, Issue 3, Pages (March 2007)
Volume 15, Issue 2, Pages (February 2007)
Volume 6, Issue 4, Pages (April 1997)
Volume 7, Issue 4, Pages (October 1997)
Live Cell Fluorescence Imaging of T Cell MEKK2
Volume 9, Issue 5, Pages (November 1998)
Volume 4, Issue 6, Pages (June 1996)
Volume 5, Issue 5, Pages (November 1996)
BLNK Immunity Volume 9, Issue 1, Pages (July 1998)
Volume 25, Issue 5, Pages (November 2006)
Volume 16, Issue 6, Pages (June 2002)
Volume 18, Issue 5, Pages (May 2003)
Volume 36, Issue 6, Pages (June 2012)
Volume 28, Issue 1, Pages (January 2008)
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
A Negative Regulatory Role for Ig-α during B Cell Development
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 15, Issue 6, Pages (December 2001)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Volume 17, Issue 2, Pages (August 2002)
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Bonnie N Dittel, IrenaŠtefanova, Ronald N Germain, Charles A Janeway 
Lck Activity Controls CD4/CD8 T Cell Lineage Commitment
Impaired Th2 Subset Development in the Absence of CD4
CD22 is a negative regulator of B-cell receptor signalling
Volume 125, Issue 4, Pages (May 2006)
Volume 31, Issue 2, Pages (August 2009)
Volume 25, Issue 5, Pages (November 2006)
Skint-1 Identifies a Common Molecular Mechanism for the Development of Interferon-γ- Secreting versus Interleukin-17-Secreting γδ T Cells  Gleb Turchinovich,
A Role for FADD in T Cell Activation and Development
Volume 4, Issue 4, Pages (April 1996)
Volume 15, Issue 5, Pages (November 2001)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 36, Issue 6, Pages (June 2012)
Volume 117, Issue 3, Pages (September 1999)
Volume 19, Issue 4, Pages (October 2003)
Volume 27, Issue 3, Pages (September 2007)
Volume 15, Issue 2, Pages (August 2001)
Volume 17, Issue 5, Pages (November 2002)
Volume 16, Issue 6, Pages (June 2002)
Volume 11, Issue 2, Pages (August 1999)
LAT Links the Pre-BCR to Calcium Signaling
Identification of Anergic B Cells within a Wild-Type Repertoire
Volume 14, Issue 1, Pages (January 2001)
Volume 7, Issue 2, Pages (August 1997)
Volume 11, Issue 3, Pages (September 1999)
SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8+ T Cells with Innate Lymphocyte Characteristics  Mihalis Verykokakis,
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 10, Issue 4, Pages (April 1999)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
The CD28 Signaling Pathway Regulates Glucose Metabolism
Volume 9, Issue 3, Pages (September 1998)
Volume 22, Issue 5, Pages (May 2005)
Volume 25, Issue 1, Pages (July 2006)
Volume 6, Issue 4, Pages (April 1997)
Volume 23, Issue 4, Pages (October 2005)
Volume 10, Issue 2, Pages (February 1999)
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Volume 8, Issue 5, Pages (May 1998)
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 25, Issue 4, Pages (October 2006)
The Influence of the MAPK Pathway on T Cell Lineage Commitment
Presentation transcript:

Volume 7, Issue 3, Pages 369-377 (September 1997) Restoration of Thymocyte Development and Function in zap-70−/− Mice by the Syk Protein Tyrosine Kinase  Qian Gong, Lynn White, Robin Johnson, Mike White, Izumi Negishi, Matthew Thomas, Andrew C Chan  Immunity  Volume 7, Issue 3, Pages 369-377 (September 1997) DOI: 10.1016/S1074-7613(00)80358-1

Figure 1 Overexpression of Syk in zap-70−/− Mice (A) Protein analysis of ZAP-70 and HA-Syk. Thymocytes (107 cells/lane, lanes 1–4) and splenocytes (107 cells/lane, lanes 5–8) were isolated from zap-70+/+, zap-70−/−, syk Tg+ zap-70−/−, and zap-70+/− mice and analyzed by Western blot analysis with an anti-ZAP-70 antiserum (top) or an anti-HA MAb (bottom). (B) Overexpression of Syk. Thymocytes (107 cells/lane) from Tg+ and Tg− littermates were analyzed by Western blot analysis with an anti-Syk antiserum (top) and an anti-Cbl antiserum (bottom). The anti-Syk immunoblot was developed using [125I]protein A, analyzed using a phosphoimager, and quantitated as described in the Experimental Procedures. Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 2 T Cell Development in Syk-Reconstituted Mice (A) Reconstitution of thymocyte development by the Syk PTK. Flow cytometric analysis of thymocytes from zap-70+/− (left), zap-70−/− (middle), and syk Tg+ zap-70−/− (right) mice. Thymocyte number of all mice was comparable to zap-70+/− mice. Representative fluorescence staining profiles of CD4 and CD8 are shown for thymocytes from littermates (top). A single parameter histogram demonstrates the relative levels of CD3 expression (bottom) (n = 6). (B) Restoration of splenic T cells by the Syk PTK. Flow cytometric analysis of splenocytes from zap-70+/− (left), zap-70−/− (middle), and Syk Tg+ zap-70−/− (right) mice. Representative fluorescence staining profiles of CD4 and CD8 are shown for splenocytes from littermates (top). A single parameter histogram demonstrates the relative levels of CD3 expression (bottom) (n = 6). Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 3 Restoration of Calcium Mobilization by the Syk PTK Thymocytes isolated from zap-70−/− (A), zap-70+/− (B), and syk Tg+ zap-70−/− (C and D) littermates were analyzed by spectrofluorimetry as described in Experimental Procedures. Cells at equilibrium were cross-linked first with a biotinylated anti-CD3ε MAb (2C11, 5 μg/ml) and subsequently with avidin (10 μg/ml) as denoted by the arrows. Thymocytes isolated from syk Tg+ zap-70−/− mice were not further cross-linked with avidin in (C). Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 4 Restoration of Cell Surface Activation Markers by the Syk PTK Thymocytes (2 × 106 cells) isolated from zap-70−/− (left), zap-70+/− (middle), or syk Tg+ zap-70−/− (right) littermates were stimulated with immobilized anti-TCRb MAb (H57–597, 10 μg/ml) and analyzed for cell surface expression of CD69 as described in Experimental Procedures. Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 5 T Cell Proliferation in Syk-Reconstituted Mice (A) Restoration of cellular proliferation in thymocytes by the Syk PTK. Thymocytes (5 × 105 cells/well) isolated from zap-70+/− (left), zap-70−/− (middle), or syk Tg+ zap-70−/− mice were incubated with media alone (open bar), immobilized anti-CD3ε MAb (2C11, 10 μg/ml, dark hatched bar), the combination of PMA and immobilized anti-CD3ε MAb (2C11, 10 μg/ml, solid gray bar), or the combination of PMA and ionomycin (open hatched bar). Incorporation of [3H]thymidine was measured at 72 hr. Samples were analyzed in triplicate and standard deviations denoted as error bars. (B) Decreased cellular proliferation of peripheral T cells expressing decreased Syk. Splenocytes (5 × 105 cells/well) isolated from zap-70+/− (left) or syk Tg+ zap-70−/− mice were incubated with media alone (open bar), immobilized CD28 MAb (37.51, 10 μg/ml; dark hatched bar), the combination of anti-CD3ε MAb (2C11, 10 μg/ml) and anti-CD28 MAb (37.51, 10 μg/ml) (solid gray bar), or the combination of anti-CD3ε MAb (2C11, 10 mg/ml) and PMA (solid black bar). Samples were analyzed in triplicate and standard deviations denoted as error bars. Splenocytes from zap-70−/− mice are not shown here since they do not have any peripheral T cells. Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 6 Requirement for CD45 in Syk Function (A) Protein expression of HA-Syk in CD45−/− derived mice. Thymocytes (107 cells/lane) from CD45+/− (lane 1), CD45−/− (lane 2), or syk Tg+ CD45−/− (lane 3) littermates were analyzed by Western blot analysis using an anti-HA MAb. (B) Requirement for CD45 for Syk function in thymocyte development. Flow cytometric analysis of thymocytes from CD45+/− (left), CD45−/− (middle), or syk Tg+ CD45−/− (right) littermates. Representative fluorescence staining profiles of CD4 and CD8 (top) are shown for littermates. Single parameter histograms demonstrate the relative levels of CD3 (middle) and CD45 (bottom) expression (n = 2). (C) Requirement for CD45 in Syk function for peripheral T cells. Flow cytometric analysis of splenocytes from CD45+/− (left), CD45−/− (middle), or syk Tg+ CD45−/− (right) littermates. Representative fluorescence staining profiles of CD4 and CD8 (top) are shown for littermates. Single parameter histograms demonstrate the relative levels of CD3 (middle) and CD45 (bottom) expression (n = 2). Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)

Figure 7 Requirement for zap-70 in γδ T Cell Development (A) Splenic γδ T cells. Splenocytes isolated from zap-70+/− (left), zap-70−/− (middle), syk Tg+ zap-70−/− (right) mice were examined by flow cytometric analysis. Representative single parameter histograms demonstrate the relative levels of γδ TCR (GL3) expression (n = 2). The dark line represents γδ TCR expression while the dotted line represents an IgG1 MAb control. (B) Intestinal intraepithelial γδ T cells. Flow cytometric analysis of intestinal intraepithelial lymphocytes were isolated from zap-70+/− (left), zap-70−/− (middle), syk Tg+ zap-70−/− (right) mice. Representative single parameter histograms demonstrate the relative levels of γδ TCR (GL3) expression (n = 2). Immunity 1997 7, 369-377DOI: (10.1016/S1074-7613(00)80358-1)